# ViroLogik

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/virologik

- Industry: Pharmaceuticals
- Headquarters: Jena, Germany
- Website: www.virologik.com
- Total disclosed funding: $24M
- Latest round: Series C (May 1, 2010)
- Investors on record: 4

## About

Established in 2006 and based in Germany, ViroLogik is a biopharmaceutical company which develops drugs for treatment of viral diseases.

## Funding rounds

- Series C, May 1, 2010, $9.1M — KfW Banking Group, S-Refit, MIG Capital, Global Asset Fund
- Series B, Dec 10, 2008, $9.5M — KfW Banking Group, S-Refit, MIG Capital
- Series A, Feb 15, 2007, $5.2M — S-Refit
- Seed, Mar 1, 2006, $0.4M — S-Refit, MIG Capital

## Investors

- S-Refit (https://capitalatlas.ai/funds/s-refit) — Seed, Series A, Series B, Series C
- MIG Capital (https://capitalatlas.ai/funds/mig-capital) — Seed, Series B, Series C
- KfW Banking Group — Series B, Series C
- Global Asset Fund — Series C